| Description | Onvatilimab (JNJ-61610588) is a human IgG1 κ-anti-Vista (T-cell-activated V-domain Ig inhibitor) monoclonal antibody. Onvatilimab has antitumor activity and can be used to treat advanced head and neck cancers. |
| Synonyms | JNJ-61610588 |
| molecular weight | N/A |
| CAS | 1969313-51-6 |
| Storage | store at low temperature | store at -80°C |
| References | 1. Katsiaryna Marhelava, et al. Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer. Cancers (Basel). 2019 Nov 8;11(11):1756. |